Cargando…

Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies

Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disorder characterized by widespread oligodendroglial cytoplasmic inclusions of filamentous α-synuclein, and neuronal loss in autonomic centres, basal ganglia and cerebellar circuits. It has been suggested that primary oligoden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Refolo, Violetta, Bez, Francesco, Polissidis, Alexia, Kuzdas-Wood, Daniela, Sturm, Edith, Kamaratou, Martina, Poewe, Werner, Stefanis, Leonidas, Angela Cenci, M., Romero-Ramos, Marina, Wenning, Gregor K., Stefanova, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753576/ https://www.ncbi.nlm.nih.gov/pubmed/29298733 http://dx.doi.org/10.1186/s40478-017-0504-y

Ejemplares similares

Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy
por: Venezia, Serena, et al.
Publicado: (2017)

Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
por: Sturm, Edith, et al.
Publicado: (2016)

L-dopa response pattern in a rat model of mild striatonigral degeneration
por: Kaindlstorfer, Christine, et al.
Publicado: (2019)

Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2015)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications
por: Schafferer, Simon, et al.
Publicado: (2016)

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2012)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

Early Motor Fluctuations in a Patient with Striatonigral Degeneration
por: Yoshii, Fumihito, et al.
Publicado: (2016)

Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2016)

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
por: Heras-Garvin, Antonio, et al.
Publicado: (2020)

Animal models of multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2015)

Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection
por: Stemberger, Sylvia, et al.
Publicado: (2011)

Multiple System Atrophy: Genetic or Epigenetic?
por: Sturm, Edith, et al.
Publicado: (2014)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence
por: Kuzdas, Daniela, et al.
Publicado: (2013)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Current experimental disease-modifying therapeutics for multiple system atrophy
por: Lemos, Miguel, et al.
Publicado: (2021)

Is Multiple System Atrophy a Prion-like Disorder?
por: Jellinger, Kurt A., et al.
Publicado: (2021)

Novel VAC14 variants identified in two Chinese siblings with childhood‐onset striatonigral degeneration
por: Liao, Shuang, et al.
Publicado: (2019)

Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2015)

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure
por: Stemberger, Sylvia, et al.
Publicado: (2010)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
por: Kallab, Martin, et al.
Publicado: (2018)

Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications
por: Kaindlstorfer, Christine, et al.
Publicado: (2015)

An Improved BAC Transgenic Fluorescent Reporter Line for Sensitive and Specific Identification of Striatonigral Medium Spiny Neurons
por: Ade, Kristen K., et al.
Publicado: (2011)

What is the Degree of Segregation between Striatonigral and Striatopallidal Projections?
por: Bertran-Gonzalez, Jesus, et al.
Publicado: (2010)

Review: Multiple system atrophy: emerging targets for interventional therapies
por: Stefanova, N., et al.
Publicado: (2016)

Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy
por: Campese, Nicole, et al.
Publicado: (2021)

Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease
por: Theisen, Frances, et al.
Publicado: (2017)

Opponent regulation of action performance and timing by striatonigral and striatopallidal pathways
por: Bakhurin, Konstantin I, et al.
Publicado: (2020)

Correction to: Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy
por: Campese, Nicole, et al.
Publicado: (2021)

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
por: Kaindlstorfer, Christine, et al.
Publicado: (2018)

Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats
por: Fieblinger, T., et al.
Publicado: (2018)

A Rat Model of Striatonigral Degeneration Generated by Simultaneous Injection of 6-Hydroxydopamine into the Medial Forebrain Bundle and Quinolinic Acid into the Striatum
por: Yoon, Hyung Ho, et al.
Publicado: (2014)

Freezing of Gait as a Complication of Pallidal Deep Brain Stimulation in DYT‐KMT2B Patients with Evidence of Striatonigral Degeneration
por: Cif, Laura, et al.
Publicado: (2022)

Corticostriatal Transmission Is Selectively Enhanced in Striatonigral Neurons with Postnatal Loss of Tsc1
por: Benthall, Katelyn N., et al.
Publicado: (2018)

Striatonigral distribution of a fluorescent reporter following intracerebral delivery of genome editors
por: Neuman, Samuel S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_10rn83grq0fb8h08qq9e8n23f3